赛诺菲（中国）投资有限公司
Chinoin Pharmaceutical and Chemical Works Private Co. Ltd.
Country: CN CDE HIGH
🇨🇳 CDE
26
26 products shown
🇺🇸 DMF
0
0 products shown
🇪🇺 CEP
0
0 products shown
Total
26
registrations
🇨🇳 CDE 注册 (26)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Amiodarone Hydrochloride 盐酸胺碘酮 | 19774-82-4 | Class A | Y20190009089 |
| Amiodarone Hydrochloride 盐酸胺碘酮 | 19774-82-4 | Class I | Y20180000626 |
| Apomorphine 盐酸阿扑吗啡 | 58-00-4 | Class I | Y20210000474 |
| Bimatoprost 贝美前列素 | 155206-00-1 | Class I | Y20190000442 |
| Cefotaxime Sodium 头孢噻肟钠 | 63527-52-6 | Class A | Y20190009083 |
| Clopidogrel 氯吡格雷 | 113665-84-2 | Class A | Y20170002333 |
| Cyanocobalamin 维生素B12 | 68-19-9 | Class A | Y20170000866 |
| Dexamethasone 地塞米松 | 50-02-2 | Class I | Y20210000129 |
| Fluticasone 丙酸氟替卡松 | 90566-53-3 | Class I | Y20190021448 |
| Glimepiride 格列美脲 | 93479-97-1 | Class A | Y20190009058 |
| Hydroxychloroquine Sulfate 盐酸地尔硫？ | 747-36-4 | Class I | Y20170001552 |
| Insulin Glargine 甘精胰岛素 | 160337-95-1 | Class A | Y20190021579 |
| Irbesartan 厄贝沙坦 | 138402-11-6 | Class A | Y20200001412 |
| Irbesartan 厄贝沙坦 | 138402-11-6 | Class I | Y20200001067 |
| Irbesartan 厄贝沙坦 | 138402-11-6 | Class A | Y20209990029 |
| Irbesartan 厄贝沙坦 | 138402-11-6 | Class I | Y20170000037 |
| Lixisenatide 利司那肽 | 320367-13-3 | Class A | Y20240000497 |
| Mecobalamin 甲钴胺 | 13422-55-4 | Class I | Y20190000022 |
| Methylprednisolone 甲泼尼龙 | 83-43-2 | Class I | Y20190000498 |
| Noscapine 那可丁 | 128-62-1 | Class I | Y20190021476 |
| Ramipril 雷米普利 | 87333-19-5 | Class A | Y20209990027 |
| Ramipril 雷米普利 | 87333-19-5 | Class I | Y20180000502 |
| Rifampicin 利福平 | 13292-46-1 | Class I | Y20210000456 |
| Sodium Valproate 丙戊酸钠/丙戊酸颗粒 | 99-66-1 | Class A | Y20170002243 |
| Valproate Sodium 丙戊酸钠 | 99-66-1 | Class A | Y20190009129 |
| Valproate Sodium 丙戊酸钠 | 99-66-1 | Class I | Y20170001920 |
Source: cde_raw | Updated: 2026-04-09 07:23:01